1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6EF752C32554A04ED00258B2E004C5DE8
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/EF752C32554A04ED00258B2E004C5DE8?OpenDocument
18
19OpenDocument
2018.97.14.81
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Education

Document Excerpt: Building a Foundational Global Function for Reviewing IME Grants: Technology, Structure, and Resources

DB Image

ID: MD-907


Features:

7 Info Graphics

11 Data Graphics

110+ Metrics

49 Narratives


Pages/Slides: 4


Published: 2024


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5807 “Building a Foundational Global Function for Reviewing IME Grants: Technology, Structure, and Resources”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Alkermes; Astellas; Baxter International; Dermavant Sciences; GRAIL; Grifols; Merck; OTSUKA; Sage Therapeutics; Sanofi; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.